4-OHA
CONCLUSION: The treatment of       premenopausal patients with triptorelin plus 4-OHA is feasible and leads to a       much greater inhibition of main circulating estrogens than treatment with the       analog alone.
CONCLUSION: The  @PREDICAT$  of       premenopausal  @OBJECT$  with triptorelin plus  @SUBJECT$  is feasible and leads to a       much greater inhibition of main circulating estrogens than treatment with the       analog alone.